Table 3.
Call to action
| Safety and efficacy trials on CBD use of pain management are needed for older adult and ethnic and racial minority populations. |
| Package labelling of CBD products needs to be accurate and enforced across the nation. |
| Uniformity in CBD ingredients and dosing across states. |
| Clinicians must be cognizant of the contents of the products they recommend. |